Long
Astera Labs | Pullback Within a Bullish Trend?After a powerful rally, Astera Labs has entered a healthy correction and is now testing the key 300-305 support area, where the Fibonacci level and the EMA 100 are located. Despite recent profit taking, price remains well above the EMA 200, keeping the long-term bullish structure intact. CCI has reached oversold territory and is beginning to recover, which may become an early signal that selling pressure is fading. As long as price holds above 300, the primary scenario remains a recovery toward 406, followed by 469 and potentially 565. A break below 300 would increase the probability of a decline toward the next major demand zone near 255. Astera Labs remains one of the fastest-growing AI infrastructure companies, providing high-speed connectivity solutions for GPUs, processors and modern data centers. The company continues to benefit from massive investment in artificial intelligence and cloud infrastructure by the world's largest technology companies. Continued revenue growth, expanding partnerships with leading server manufacturers and rising AI infrastructure spending could support the stock's long-term bullish outlook. 
Long
Long
$ABT When the Reason for the Markdown ReversesWhat I'm seeing
ABT peaked ~$137 in mid-2025 and bled 40% to $81.97 a textbook Weinstein Stage 4 markdown while the broader market ran. The week of July 13 changed the tape: a massive bullish engulfing candle on the highest weekly volume in months, reclaiming $100 off the Fib 0% floor.
- Fib 0% ($81.97) tested and rejected hard
- Weekly close $100.68, back above the 200-week EMA zone
- 4H structure flipped: price above Value Area High ($100.67), above anchored VWAP/PoC at $95.10 — recent buyers are in profit, and the high-volume node at $95 is now the floor, not the ceiling
- Weekly RSI recovering from deep oversold
- Insider buying into the lows, zero selling
Why it matters
The markdown was never an earnings problem. Revenue grew every quarter through the decline. The stock was repriced on one thing: the April guidance cut from Exact Sciences dilution, plus litigation and competition fears stacked on top.
On July 16, that exact driver reversed. Q2 beat. Full-year guidance *raised* back to $5.45–$5.60. The market marked the stock down on lowered guidance and just got handed raised guidance at a 23-handle lower price.
When the cause of a Stage 4 gets invalidated, the markdown loses its fuel. That's the setup. Not the confirmation the setup.
The levels
- $94–95 — line in the sand. VWAP + PoC + volume shelf. Bulls must defend this or the reversal thesis dies.
- $103.18 — first real test (Fib 0.382). Acceptance above opens the next leg.
- $112–116 — the decision zone (Fib 0.618 + prior structure). This is where a bounce becomes a trend change or gets sold.
- $137.49 — prior high. Not a target yet. A destination only if the base builds.
What I expect
Default assumption after 40% of markdown: overhead supply exists at every level above. One candle even a monster proves a floor, not a trend.
Two conditions, no predictions:
Weekly acceptance above $103 = first evidence the repricing is done and Stage 1 accumulation is underway. Until then, this is a violent bounce with a good story.
Loss of $94 on a weekly close = the engulfing candle was distribution's gift, not accumulation's start. Back to watchlist.
Strong business + reversed catalyst + reclaimed structure earns real attention. It does not earn full size.
Patience is a position. Not financial advice educational breakdown of my process. 
Long
Short
Long
Long
TSLA Earning Week Option Trades TSLA has been grinding inside a broad consolidation after failing to sustain the early-July push, with price repeatedly reacting around the 391.00 and 381.00 zones. The chart is also respecting a descending trendline from the early-month highs, while 406.00 and 412.00 remain the first major upside hurdles if buyers can regain momentum.
Earnings next week are the main catalyst, and the implied move shown on the chart should be treated as fluid until closer to the report. I’m using two main earnings paths here: a continuation move in green and an overreaction move in red.
I've mapped out three scenarios for the coming sessions:
🟢 Bullish Scenario
If TSLA reclaims 391.00 and then pushes through 406.00, the path opens toward 412.00 and eventually the 429.55 daily level. This is the continuation setup, but it needs strength above the overhead trendline and clean acceptance back into the upper range.
🔴 Bearish Scenario (My Lean)
This is the scenario I'm leaning toward. If 380.05 fails and TSLA loses 381.00, the next clean downside targets are 370.00 and 364.00, with a deeper flush toward the red implied move zone near 354.00 possible on an earnings overreaction. A deceptively bullish drift into earnings could still roll over hard, so I’d be watching for rejection near 391.00 and failed intraday rebounds.
🟡 Sideways Scenario
If TSLA stays boxed between 381.00 and 391.00, expect chop and compression ahead of earnings. In that zone, theta decay and IV expansion risk can make premium bleed quickly unless momentum breaks one of those boundaries. While possible I just don't see this chopping sideways through earnings
Earnings & Implied Move
The chart shows a wide implied move window into earnings, with a green upside range near 406.00 and a red downside range near 354.00. IV should stay elevated into the report, but IV crush after earnings can punish anyone chasing premium too early, which is why I prefer defined-risk setups and quick reaction trades over holding through the event.
My Outlook
If I had to rank the probabilities today:
🔴 Bearish (my current lean)
🟢 Bullish breakout
🟡 Sideways consolidation
That ranking can change quickly if TSLA reclaims 391.00 and especially 406.00 with momentum, but until then I’m respecting the downside risk and the possibility of a post-earnings overreaction.
Side these scenarios can go both ways with a continuation and sell of lower and you can see overreactions on bullish runs this was just the way I chose to illustrate it
As always, the Heavy Diligence Options Signals Indicator will be my primary tool for entries and exits. While these scenarios provide the broader roadmap, the indicator is designed primarily for day trading on shorter timeframes, helping identify higher-probability Call and Put opportunities. Combining those signals with key technical levels helps improve risk management instead of simply guessing the next move.
Disclaimer: This is only my interpretation of the current chart and is not financial advice. Always do your own research, wait for confirmation, and manage your risk before entering any trade. 
Short
$SKHY (ADR): Experiencing the Same Selloff Pattern as $SPCX ?Looking at the chart, I noticed that NASDAQ:SKHY (ADR) is showing a remarkably similar selloff pattern to NASDAQ:SPCX .
During the U.S. market open on July 17, NASDAQ:SKHY briefly broke below its IPO price of $149 , then staged a strong recovery and rallied back to test the 0.382 Fib retracement . The price action closely mirrors what we previously saw in $SPCX.
In one of my Ideas last week, I wrote:
"If NASDAQ:SPCX breaks below the $150 low, the next downside target is around $130. If selling pressure continues, the decline could even extend toward $84."
Applying the same technical framework, if NASDAQ:SKHY fails to reclaim the $168 key level next week, the stock could be setting up for another leg lower, with the $135 area becoming the next major downside target.
Another factor worth watching is the current valuation gap. NASDAQ:SKHY (ADR) is trading at roughly a 25% premium to its Korea-listed shares.
On July 29 , the ADRs and the Korea-listed shares will become mutually convertible. This event is likely to compress that premium—either through a decline in the U.S.-listed ADR, an appreciation in the Korean shares, or a combination of both.
That said, while the ADR may remain under pressure in the short term, the long-term fundamentals remain intact. The structural DRAM supply shortage and continued HBM demand have not changed, and I remain bullish on the memory semiconductor sector over the long run.
If you also like planning your U.S. stock trades over the weekend—without constantly switching between Gold, Crypto, and stock trading apps—you should check out rToken.
Unlike synthetic assets that rely on price oracles or on-chain liquidity pools, Bitget's rToken routes orders through broker channels directly to the real NASDAQ and NYSE order books, enabling 24/7 trading while preserving real U.S. equity liquidity with the efficiency of the crypto market.
It brings together the best of both worlds: authentic stock market execution and around-the-clock crypto trading. 
Long
Short
Long
Long
IRS - Can Buyers Defend the Broader Uptrend?IRS is one of Argentina's largest real estate companies, with a diversified portfolio that includes shopping centers, office buildings, hotels, and residential developments. The stock is often followed by investors seeking exposure to the Argentine real estate sector.
From a technical perspective, the stock remains overall bullish, continuing to trade inside the red ascending broadening wedge that has guided the long-term trend.
Following the rejection from the upper red resistance area, price is approaching an important technical region where the lower boundary of the broadening wedge aligns with a blue support zone.
⭕As price approaches this support area, we can start looking for trend-following buy setups on lower timeframes, anticipating a potential continuation of the broader bullish trend.
⭕However, if price breaks below the current support zone, the focus shifts toward the next lower support area, where buyers may become active once again.
Price action around this technical region may reveal whether the broader bullish structure remains intact, or if sellers have other plans.
⚠️ Disclaimer: This analysis reflects my personal market view and is not financial advice.
Rayan Nasser
#IRS #Stocks #Investing #TechnicalAnalysis #PriceAction #MarketStructure #TrendAnalysis 
Long
MSFT | Deep Correction Complete—Bulls Target The Liquidity Above
By analyzing the #MSFT (Microsoft) chart on the 4H timeframe, we can see that the broader trend remains bullish, and the deep correction that shook out weak hands looks to be complete. Price has reclaimed structure off a key demand area, and the setup now points toward the liquidity resting overhead.
📊 4H Timeframe
On the 4H, the bigger picture is an uptrend that went through a deep corrective phase inside a descending channel. Two things then flipped the script: price printed an internal CHoCH (iCHoCH), signaling the correction was losing steam — and then, on the push lower into the Demand Zone ( $344.31 – $365.42 ), it executed a clean liquidity sweep, running the stops resting below before launching higher with force. That's the classic trap: take the liquidity, then reverse.
Since reclaiming from demand, price has been grinding higher and is now building a smaller corrective channel after the last leg up, trading around $394.03 . A break of this corrective channel to the upside is the trigger that opens the door toward the stacked buy-side liquidity (BSL) overhead at $466.21 , $489.53 , and ultimately $555.39 . The entire bullish thesis stays valid as long as price holds above the Protected Low at $344.31 , with deeper structural support at $310.25 .
🎯 The Bias
My base case is bullish continuation. The trend is up, the deep correction completed with an iCHoCH and a liquidity sweep into demand, and price has already reclaimed with strength. The trigger is a break of the current corrective channel to the upside — on that break, the draw is toward the BSL pools above ($466.21 → $489.53 → $555.39). In my view, as long as MSFT holds above the Protected Low ($344.31), every dip remains a buying opportunity rather than a reversal — the sweep already did its job of clearing the sellers.
📰 Fundamental Backdrop
The bullish structure lines up with a compelling fundamental setup. Microsoft has been the laggard of the "Magnificent Seven," down roughly 20% year-to-date and about 29% from its record high, as investors punished the sector over fears that AI could disrupt legacy software — but that sell-off has left the stock at its cheapest forward multiple since 2023 (around 20–22x earnings), which many analysts frame as a rare entry point. The next major catalyst is fiscal Q4 earnings on July 29, and sentiment into it is constructive: the prior quarter beat with $81.3 billion in revenue (up 17% YoY), and analysts widely expect the print to spark a recovery. The Street is overwhelmingly bullish — the average target sits around $559–592 (well above current price), with fresh Buy reiterations citing Azure and M365 tailwinds plus underappreciated earnings power, and Microsoft just overhauled its cybersecurity unit to monetize AI-driven threats. The risk to respect: the enormous AI capex bill (FY2026 guidance up near $190 billion, ~61% higher YoY) is growing faster than revenue and could pressure margins — so the July 29 commentary on spend and Azure growth is the real test. But with the valuation reset and earnings imminent, the fundamental picture aligns with the bullish technical read.
This analysis will be updated as the market evolves. If this breakdown added value, drop a like 👍 and a comment 💬 to support the work — and share where you see Microsoft heading next! Best Regards, BigBeluga 🐳 
Short
Long
